Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR).  German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed.  Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE.  In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups.
TAVR
Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR).  German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed.  Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE.  In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups.
TAVR
Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR).  German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed.  Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE.  In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups.
TAVR
Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR).  German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed.  Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE.  In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups.
TAVR
Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR).  German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed.  Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE.  In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups.
TAVR
Previously, overall comparable outcomes were seen for balloon-expandable (BE) or self-expanding (SE) transfemoral transcatheter aortic valve replacement (TAVR).  German national data of all BE and SE transfemoral TAVR treating aortic valve stenosis in 2019 and 2020 were analysed.  Overall, 46,243 TAVR were analysed, 19,910 BE, and 26,333 SE.  In the direct comparison of balloon-expandable and self-expanding TAVR, there are no differences for in-hospital mortality in subgroups.
TAVR